Page 155 - 2023 Taiwan Health and Welfare Report
P. 155

12                                                                               Research, Development, and      12
                                                                                      International Cooperation



                       National Health Research Institutes collaborated   high-density storage devices and remote connection
                       with ASUS Cloud and NVIDIA to establish the   software for the "Health Big Data Zone." In addition,
                       "Artificial Intelligence Biotechnology Research   a process has been devised in collaboration with the
                       Center" (AIBMRC). This center aims to apply AI   NHRI to bring in the NHRI Biobank, and perform data
                       technology in the field of intelligent healthcare   encryption and matching applications.
                       and  medical  care,  thereby  assisting  in  the   2. Service Content and Service Quantity
                       development of  Taiwan's  precision  health
                                                                    In 2022, the number of database opened for application
                       strategic industry policies.
                                                                    was adjusted to 97, and 125 computers were provided
                    (6)  Promoting multi-institutional research in Cancer   to daily services. As the COVID-19 pandemic subsided,
                       Translational Research Program               there was an increase of over 20% in the person-days
                       In the optimization of cancer treatment guidelines,   of service, the case-times of actual usage in the year,
                       this project has discovered that early-stage liver   and the case-times of reviewed statistic result carried
                       cancer patients achieve optimal therapeutic   out. (shown in Table 12-1)
                       efficacy by selecting surgery or ablative therapy   3. Promoting Database Leading to R&D of Biomedicine
                       based on patient age. Among chronic hepatitis
                                                                    (1)  The "Health Big Data Sustainable Platform" inter-
                       B patients who experience recurrence after
                                                                       ministerial project completed the construction of
                       discontinuation of antiviral therapy, those who
                                                                       the "Taiwan Health Big Data Integration Service
                       receive intermittent treatment for the second
                                                                       Platform" information portal, which was made
                       time have a higher risk of liver cancer compared
                                                                       available to the public on October 15, 2022.
                       to those receiving continuous treatment. The
                                                                       The service portal, designed with a user-centric
                       project has also accomplished the development
                                                                       approach, serves as a single gateway, focusing
                       of treatment protocols for adult Philadelphia
                                                                       on the needs of industry users to facilitate the
                       chromosome-positive acute lymphoblastic
                                                                       generation of commercial value.
                       leukemia in young adults and adolescents, as
                                                                    (2)  The "Collaborative Demonstration Project
                       well as the draft of the 4th edition guidelines for
                                                                       for Precision Cancer Medicine and Biobank
                       the management of myelodysplastic syndromes.
                                                                       Integration Platform" marked the first large-
                  Section 3  Application Service of Health             scale international collaboration project between
                              and Welfare Research                     the public and private (industry) sectors under
                                                                       the MOHW. In 2022, Roche Pharmaceuticals
                  1. Management of Applications Service Platform
                                                                       submitted a data application in compliance with
                    The Health and Welfare Data Science Center (HWDC)
                                                                       regulations, symbolizing Taiwan's alignment with
                    has continued to collaborate with the "Health
                                                                       international developments in precision medicine.
                    Big Data Sustainable Platform" project in 2022,
                    successfully completing the installation and setup of























                   ● Opening ceremony of AIBMRC

 152                                                                                                             153
   150   151   152   153   154   155   156   157   158   159   160